| Type of Material: | Thesis |
| Title: | Adoption of Digital Health Initiatives in Chronic Disease Segment in Patient Engagement Domain by Pharmaceutical Companies Triggers and Impact |
| Researcher: | Jathal, Keyur |
| Guide: | Mehta, Bindi |
| Department: | Institute of Management |
| Publisher: | Nirma University, Ahmedabad |
| Place: | Ahmedabad |
| Year: | 2023 |
| Language: | English |
| Subject: | Clinical Medicine | Clinical Pre Clinical and Health | Covid-19 | DHI | Primary Health Care | Medical Sciences | Medical and Health Sciences |
| Dissertation/Thesis Note: | PhD; Institute of Management, Nirma University, Ahmedabad, Ahmedabad; 2023 |
| Fulltext: | Shodhganga |
| 000 | 00000ntm a2200000ua 4500 | |
| 001 | 456649 | |
| 003 | IN-AhILN | |
| 005 | 2024-10-11 16:55:06 | |
| 008 | __ | 241011t2023||||ii#||||g|m||||||||||eng|| |
| 035 | __ | |a(IN-AhILN)th_456649 |
| 040 | __ | |aNIRU_382481|dIN-AhILN |
| 041 | __ | |aeng |
| 100 | __ | |aJathal, Keyur|eResearcher |
| 110 | __ | |aInstitute of Management|bNirma University, Ahmedabad|dAhmedabad|ein|0U-0146 |
| 245 | __ | |aAdoption of Digital Health Initiatives in Chronic Disease Segment in Patient Engagement Domain by Pharmaceutical Companies Triggers and Impact |
| 260 | __ | |aAhmedabad|bNirma University, Ahmedabad|c2023 |
| 300 | __ | |dDVD |
| 502 | __ | |cInstitute of Management, Nirma University, Ahmedabad, Ahmedabad|d2023|bPhD |
| 518 | __ | |d2023|oDate of Award |
| 518 | __ | |oDate of Registration|d2014 |
| 520 | __ | |aAbstract Chronic diseases are the largest contributors to the Global Burden of Disease. As per World Health Organization, 41 million people died of non-communicable diseases. In India, chronic diseases account for 60% of deaths nationally. Covid-19 pandemic-induced lockdowns made remote patient engagement a necessity and digital health assumed unprecedented importance as managing chronic diseases was a global priority. Digital health initiatives (DHI) in the form of mobile health (mhealth) apps, virtual consultations, connected and wearable devices, gained prominence for remote patient engagement. The objective of this research was to seek an understanding on the adoption of DHI by pharmaceutical companies, in the patient engagement domain for managing chronic diseases. Research questions focused on the types of DHI adopted, along with the triggers for adoption and the impact. An integrated approach of the Technology-Organization- Environment (TOE) framework and the Iacovou model was treating a guiding refe |
| 650 | __ | |aMedical Sciences|2UGC |
| 650 | __ | |aMedical and Health Sciences|2AIU |
| 653 | __ | |aClinical Medicine |
| 653 | __ | |aClinical Pre Clinical and Health |
| 653 | __ | |aCovid-19 |
| 653 | __ | |aDHI |
| 653 | __ | |aPrimary Health Care |
| 700 | __ | |eGuide|aMehta, Bindi |
| 856 | __ | |uhttp://shodhganga.inflibnet.ac.in/handle/10603/493711|yShodhganga |
| 905 | __ | |afromsg |
User Feedback Comes Under This section.